Released Nov 7, 2016, after the close
10-Q filed Nov 7, 2016, 38 days after period end · 0001558370-16-009519
Q3 2016 · 10-Q
Revenue$66.11M$66.11M +67.1% vs Q3 2015+21.6% vs Q2 2016
Net Income-$33.20M-$33.20M no prior Q3 2015 on fileN/M vs Q2 2016
EPS Diluted-$0.23-$0.23 N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$28,287,000N/M
Operating Cash Flowderived-$645,000N/M
Free Cash Flowderived-$2,030,000N/M
Margins · derived
Operating margin-42.8%+23.4 pt vs Q3 2015
Net margin-50.2%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $66.11M | $39.57M | $16.92M | $4.93M |
| Net Income | -$33.20M | — | — | -$61.78M |
| EPS Diluted | -$0.23 | -$0.33 | -$0.30 | -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR